SÜSS MicroTec (SMHN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 May, 2026Company profile and strategic positioning
Headquartered in Germany with a 75-year history of innovation, serving the global semiconductor industry, especially in Asia.
Acts as a key technology provider for both frontend and advanced backend semiconductor processes.
Maintains strong partnerships with global IDMs, foundries, and research institutions.
Management board oversees finance, sales, R&D, production, and ESG initiatives.
Product portfolio and innovation
Offers solutions in photomask equipment, imaging, coating, and bonding for both frontend and backend segments.
Market leader in temporary and hybrid wafer bonding, with recent launches targeting high-volume manufacturing and R&D.
Upcoming product introductions include advanced photomask cleaning, hybrid bonding, and inkjet coating platforms.
Focused on supporting next-generation semiconductor nodes and advanced packaging technologies.
Financial performance and outlook
Q1 2026 order intake reached €149.3m (+69.5% YoY), but sales declined 30.7% YoY to €86.5m.
Gross profit margin for Q1 2026 was 36.1%, with EBIT margin at 4.3%, both down from prior year due to lower cost coverage.
2026 is expected to be a transition year with sales guidance of €425–485m, gross margin 35–37%, and EBIT margin 8–10%.
Long-term ambitions for 2030 include sales of €750–900m, gross margin 43–45%, and EBIT margin 20–22%.
Latest events from SÜSS MicroTec
- Record orders and strong margins support robust growth outlook through 2027 and beyond.SMHN
Industrial Technology Online Investor Conference - Record order intake and strong order book offset lower H1 sales, supporting 2026 guidance.SMHN
Q2 2026 - Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 2025 - Revenue set to double by 2030, fueled by innovation, service growth, and margin expansion.SMHN
CMD 2025 - Sales up 45.6%, EBIT margin 15.6%, and guidance raised after strong order intake.SMHN
Q2 2024 - Record sales and profitability in 2024 set a strong outlook for 2025.SMHN
Q4 2024